Observational studyRheumatology (Oxford, England)2020

Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics Register.

Katie Bechman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.